Palbociclib in Combination With Lenalidomide and Dexamethasone for Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Dexamethasone
Related studies linked through entity extraction aliases.
Eclampsia and Posterior Reversible Encephalopathy Syndrome (PRES):
- Status
- TERMINATED
- Phase
- NA
Combination of G-CSF, Bortezomib, Cyclophosphamide and Dexamethasone in Patients With Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE2
Ultrasound Guided Trigeminal Nerve Block for Typical or Atypical Facial Pain
- Status
- COMPLETED
- Phase
- PHASE4
Ketamine in Post-operative Dental Pain and Recovery
- Status
- COMPLETED
- Phase
- PHASE3
Carfilzomib in Treating Patients With Multiple Myeloma in First Relapse or Refractory to First-Line Therapy
- Status
- TERMINATED
- Phase
- PHASE2
Japanese Phase 2 Study to Evaluate the Efficacy and Safety of Pomalidomide in Subjects With Relapsed and Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Carfilzomib With Bendamustine and Dexamethasone in Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of Oprozomib, Pomalidomide, and Dexamethasone in Adults With Primary Refractory or Relapsed and Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
A Study of JNJ-54767414 (HuMax CD38) (Anti-CD38 Monoclonal Antibody) in Combination With Backbone Treatments for the Treatment of Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Bortezomib and Dexamethasone Followed by ASCT Compared With ASCT Alone in Treating Patients With AL Amyloidosis
- Status
- COMPLETED
- Phase
- PHASE3
GAD-M Regimen As First-Line Treatment in Untreated Extranodal NK/T Cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Revlimid / All-Trans Retinoic Acid (ATRA) / Dexamethasone in Relapsed/Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Multicenter, Open-label, Phase 1b Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Pomalidomide, Dexamethasone, and Romidepsin for Rel/Ref Myeloma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
High-dose Dexamethasone Combining Thalidomide Versus Dexamethasone Mono-therapy for Management of Newly-diagnosed ITP
- Status
- WITHDRAWN
- Phase
- PHASE2